Comparison between convective radiofrequency water vapor thermal ablation (Rezum) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement
Uro-Technology Journal · 25.12.2025 · 9 (4)
DOI: 10.31491/utj.2025.12.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Uro-Technology Journal, online erschienen am 31.12.2025. Verfasst von Khaled Abdelsattar Gad Ibrahim und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ibrahim, K. A. G., Meshref, A. E. W., El-Rassoul, M. A. A., Bassiony, M. W., Elsayed, A. S., & Ibrahim, H. (2025). Comparison between convective radiofrequency water vapor thermal ablation (Rezum) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement. Uro-Technology Journal, 9(4). https://doi.org/10.31491/utj.2025.12.050
Vancouver
Ibrahim KAG, Meshref AEW, El-Rassoul MAA, Bassiony MW, Elsayed AS, Ibrahim H. Comparison between convective radiofrequency water vapor thermal ablation (Rezum) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement. Uro-Technology Journal. 2025;9(4). doi:10.31491/utj.2025.12.050
BibTeX
@article{Ibrahim2025,
author = {Ibrahim, Khaled Abdelsattar Gad and Meshref, Alaa El-Din Wafik and El-Rassoul, Mohammed Abdou Abd and Bassiony, Mohammed Wagieh and Elsayed, Ahmed Salah and Ibrahim, Hassan},
title = {Comparison between convective radiofrequency water vapor thermal ablation (Rezum) versus tamsulosin in management of lower urinary tract symptoms in patients with benign prostatic enlargement},
journal = {Uro-Technology Journal},
year = {2025},
volume = {9},
number = {4},
doi = {10.31491/utj.2025.12.050}
}
EUVIMED